CoChat

Advancing pharmacy and healthcare with virtual digital technologies

Open access
Trenfield, Sarah J., Awad, Atheer, McCoubrey, Laura E., Elbadawi, Moe, Goyanes, Alvaro, Gaisford, Simon, Basit, Abdul W. · 2022 · Advanced Drug Delivery Reviews
Cited by 178

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Digitalisation of the healthcare sector promises to revolutionise patient healthcare globally. From the different technologies, cyber tools including artificial intelligence, blockchain, virtual, and augmented reality, to name but a few, are providing significant benefits to patients and the pharmaceutical sector alike, ranging from improving access to clinicians and medicines, as well as improving real-time diagnoses and treatments. Indeed, it is envisioned that such technologies will communicate together in real-time, as well as with their physical counterparts, to create a large-scale, cyber healthcare system. Despite the significant benefits that cyber-based digital health technologies can bring to patient care, a number of challenges still remain, ranging from data security to acceptance within the healthcare sector. This review provides a timely account of the benefits and challenges of cyber-based health interventions, as well an outlook on how such technologies can be transitioned from research-focused towards real-world healthcare and pharmaceutical applications to transform treatment pathways for patients worldwide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2021.114098

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 138

  1. Hassanalieragh, 2015, Health Monitoring and Management Using Internet-of-Things (IoT) Sensing with Cloud-Based Processing: Opportunities and Challenges, Proceedings - 2015 IEEE International Conference on Services Computing, SCC, 2015, 285, 10.1109/SCC.2015.47 · DOI · Paper page
  2. Elbadawi, 2020, Advanced machine-learning techniques in drug discovery, Drug Discov. Today, 26, 769, 10.1016/j.drudis.2020.12.003 · DOI · Paper page
  3. Schuhmacher, 2020, The upside of being a digital pharma player, Drug Discov. Today, 25, 1569, 10.1016/j.drudis.2020.06.002 · DOI · Paper page
  4. Schuhmacher, 2019, The Art of Virtualizing Pharma R&D, Drug Discov. Today, 24, 2105, 10.1016/j.drudis.2019.07.004 · DOI
  5. Fedorov, 2021, Towards practical applications in quantum computational biology, Nature Computational, Science, 1, 114
  6. Wang, 2021, Computational pharmaceutics - A new paradigm of drug delivery, J. Control. Release, 338, 119, 10.1016/j.jconrel.2021.08.030 · DOI · Paper page
  7. Trenfield, 2019, Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks, Int. J. Pharm., 567, 118443, 10.1016/j.ijpharm.2019.06.034 · DOI
  8. Medina, 2016, Counterfeit medicines in Peru: a retrospective review (1997–2014), BMJ Open, 6, 10.1136/bmjopen-2015-010387 · DOI
  9. Clark, 2018, Blockchain, IP and the pharma industry—how distributed ledger technologies can help secure the pharma supply chain, J. Intellectual Property Law & Practice, 13, 531, 10.1093/jiplp/jpy069 · DOI
  10. Singh, 2020, Internet of Things Based Blockchain for Temperature Monitoring and Counterfeit Pharmaceutical Prevention, Sensors, 20, 3951, 10.3390/s20143951 · DOI · Paper page
  11. Amazon, Introducing Amazon Pharmacy: Prescription Medications Delivered, 2020. https://press.aboutamazon.com/news-releases/news-release-details/introducing-amazon-pharmacy-prescription-medications-delivered.
  12. Gulliford, 1998, Using telemedicine technology for pharmaceutical services to ambulatory care patients, Am. J. Health-Syst. Pharm., 55, 1512, 10.1093/ajhp/55.14.1512 · doi:10.1093/ajhp/55.14.1512
  13. Kichloo, 2020, Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA, Fam Med Community Health, 8, e000530, 10.1136/fmch-2020-000530 · DOI · Paper page
  14. Papastergiou, 2009, Exploring the potential of computer and video games for health and physical education: A literature review, Comput. Educ., 53, 603, 10.1016/j.compedu.2009.04.001 · DOI · Paper page
  15. Motraghi, 2014, Virtual reality exposure therapy for the treatment of posttraumatic stress disorder: a methodological review using CONSORT guidelines, J. Clin. Psychol., 70, 197, 10.1002/jclp.22051 · DOI · Paper page
  16. Halic, 2014, MoMiReS: Mobile mixed reality system for physical & occupational therapies for hand and wrist ailments, IEEE Innovations in Technology Conference, 2014, 1
  17. Yang, 2021, A Novel Mobile Application for Medication Adherence Supervision Based on AR and OpenCV Designed for Elderly Patients, Int. Conf. Human-Computer Interaction, Springer, 335
  18. Hussein G., Kawahara N., Adaptive and longitudinal pharmaceutical care instruction using an interactive voice response/text-to-speech system, American journal of pharmaceutical education, 70 (2006) 37-37. · doi:10.1016/s0002-9459(24)07679-4
  19. Liu, 2018, Using virtual reality for drug discovery: a promising new outlet for novel leads, Expert Opin. Drug Discov., 13, 1103, 10.1080/17460441.2018.1546286 · DOI
  20. Eleftheriadis, 2021, Modular design principle based on compartmental drug delivery systems, Adv. Drug Deliv. Rev., 178, 10.1016/j.addr.2021.113921 · DOI
  21. Awad, 2021, Connected Healthcare: Improving Patient Care using Digital Health Technologies, Adv. Drug Deliv. Rev., 178, 113958, 10.1016/j.addr.2021.113958 · DOI · Paper page
  22. Henstock, 2019, Artificial Intelligence for Pharma: Time for Internal Investment, Trends Pharmacol. Sci., 40, 543, 10.1016/j.tips.2019.05.003 · DOI
  23. Pollard, 2021, Electrochemical biosensors: a nexus for precision medicine, Drug Discov Today, 26, 69, 10.1016/j.drudis.2020.10.021 · DOI
  24. Ong, 2021, Optical biosensors - Illuminating the path to personalized drug dosing, Biosens. Bioelectron., 188, 113331, 10.1016/j.bios.2021.113331 · DOI
  25. Collobert, 2011, Natural language processing (almost) from scratch, J. Machine Learning Research, 12, 2493
  26. Zemmar, 2020, The rise of robots in surgical environments during COVID-19, Nature, Machine Intelligence, 2, 566
  27. Mesko, 2020, A short guide for medical professionals in the era of artificial intelligence, NPJ Digit Med, 3, 126, 10.1038/s41746-020-00333-z · DOI · Paper page
  28. Badillo, 2020, An Introduction to Machine Learning, Clin. Pharmacol. Ther., 107, 871, 10.1002/cpt.1796 · DOI · Paper page
  29. May, 2021, Eight ways machine learning is assisting medicine, Nat. Med., 27, 2, 10.1038/s41591-020-01197-2 · DOI
  30. FDA approves stroke-detecting AI software, Nature Biotechnology, 36 (2018) 290-290. · DOI
  31. Golan, 2020, AI-powered stroke triage system performance in the wild, J. Experimental Stroke Translational Medicine, 12
  32. Abdelrahman, 2021, Convolutional neural networks for breast cancer detection in mammography: A survey, Comput. Biol. Med., 131, 104248, 10.1016/j.compbiomed.2021.104248 · DOI · Paper page
  33. Knoops P.G.M., Papaioannou A., Borghi A., Breakey R.W.F., Wilson A.T., Jeelani O., Zafeiriou S., Steinbacher D., Padwa B.L., Dunaway D.J., Schievano S., A machine learning framework for automated diagnosis and computer-assisted planning in plastic and reconstructive surgery, Scientific reports, 9 (2019) 13597-13597. · DOI
  34. Ravi, 2017, Deep Learning for Health Informatics, IEEE J. Biomed. Health. Inf., 21, 4, 10.1109/JBHI.2016.2636665 · DOI · Paper page
  35. Bannigan, 2021, Machine learning directed drug formulation development, Adv. Drug Deliv. Rev., 175, 113806, 10.1016/j.addr.2021.05.016 · DOI · Paper page
  36. Bhhatarai, 2019, Opportunities and challenges using artificial intelligence in ADME/Tox, Nat. Mater., 18, 418, 10.1038/s41563-019-0332-5 · DOI · Paper page
  37. Chan, 2019, Advancing Drug Discovery via Artificial Intelligence, Trends Pharmacol. Sci., 40, 592, 10.1016/j.tips.2019.06.004 · DOI · Paper page
  38. Elbadawi, 2021, Disrupting 3D printing of medicines with machine learning, Trends Pharmacol. Sci., 42, 745, 10.1016/j.tips.2021.06.002 · DOI
  39. Elbadawi, 2020, M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines, Int. J. Pharm., 590, 10.1016/j.ijpharm.2020.119837 · DOI · Paper page
  40. Lester, 2021, Human versus machine editing of electronic prescription directions, J. Am. Pharm. Assoc., 61, 484, 10.1016/j.japh.2021.02.006 · DOI
  41. Nimri, 2020, Decision Support Systems for Insulin Treatment Adjustment in People with Type 1 Diabetes, Pediatr Endocrinol Rev, 17, 170
  42. Nimri, 2018, Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians, Diabetes Obes. Metab., 20, 2458, 10.1111/dom.13408 · DOI
  43. Chen, 2017, Developing an in silico pipeline for faster drug candidate discovery: Virtual high throughput screening with the Signature molecular descriptor using support vector machine models, Chem. Eng. Sci., 159, 31, 10.1016/j.ces.2016.02.037 · DOI
  44. Ashiru, 2008, Polyethylene Glycol 400 Enhances the Bioavailability of a BCS Class III Drug (Ranitidine) in Male Subjects but Not Females, Pharm. Res., 25, 2327, 10.1007/s11095-008-9635-y · DOI
  45. McCoubrey, 2021, Predicting drug-microbiome interactions with machine learning, Biotechnol. Adv., 54, 107797, 10.1016/j.biotechadv.2021.107797 · DOI · Paper page
  46. Ding, 2021, DeepBAR: A Fast and Exact Method for Binding Free Energy Computation, J. Physical Chem. Lett., 12, 2509, 10.1021/acs.jpclett.1c00189 · DOI
  47. Mamoshina, 2018, Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification, Front. Genet., 9, 242, 10.3389/fgene.2018.00242 · DOI · Paper page
  48. McCoubrey, 2021, Machine Learning Uncovers Adverse Drug Effects on Intestinal Bacteria, Pharmaceutics, 13, 1026, 10.3390/pharmaceutics13071026 · DOI
  49. Ståhl, 2019, Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design, J. Chem. Inf. Model., 59, 3166, 10.1021/acs.jcim.9b00325 · DOI · Paper page
  50. Yamada, 2019, Predicting Materials Properties with Little Data Using Shotgun Transfer Learning, ACS Cent. Sci., 5, 1717, 10.1021/acscentsci.9b00804 · DOI · Paper page
  51. Chen, 2020, Generative Deep Neural Networks for Inverse Materials Design Using Backpropagation and Active Learning, Adv. Sci., 7, 1902607, 10.1002/advs.201902607 · DOI · Paper page
  52. Reker, 2019, Practical considerations for active machine learning in drug discovery, Drug Discovery Today: Technologies, 32-33, 73, 10.1016/j.ddtec.2020.06.001 · DOI
  53. Fujiwara, 2008, Virtual Screening System for Finding Structurally Diverse Hits by Active Learning, J. Chem. Inf. Model., 48, 930, 10.1021/ci700085q · doi:10.1021/ci700085q
  54. Kangas, 2014, Efficient discovery of responses of proteins to compounds using active learning, BMC Bioinf., 15, 143, 10.1186/1471-2105-15-143 · DOI
  55. Baskin, 2020, The power of deep learning to ligand-based novel drug discovery, Expert Opin. Drug Discov., 15, 755, 10.1080/17460441.2020.1745183 · DOI · Paper page
  56. Maragakis, 2020, A Deep-Learning View of Chemical Space Designed to Facilitate Drug Discovery, J. Chem. Inf. Model., 60, 4487, 10.1021/acs.jcim.0c00321 · DOI
  57. Bahi, 2018, Drug-Target Interaction Prediction in Drug Repositioning Based on Deep Semi-Supervised Learning, IFIP Adv. Information Communication Technology, 302
  58. Reker, 2015, Active-learning strategies in computer-assisted drug discovery, Drug Discovery Today, 20, 458, 10.1016/j.drudis.2014.12.004 · DOI · Paper page
  59. Li, 2015, Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology, Eur. J. Pharm. Biopharm., 94, 170, 10.1016/j.ejpb.2015.04.028 · DOI
  60. Manda, 2019, An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System, Pharmaceutics, 11, 109, 10.3390/pharmaceutics11030109 · DOI
  61. Narayanan, 2021, Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation, Trends Pharmacol. Sci., 42, 151, 10.1016/j.tips.2020.12.004 · DOI · Paper page
  62. Lou, 2021, Applications of Machine Learning in Solid Oral Dosage Form Development, J. Pharm. Sci., 110, 3150, 10.1016/j.xphs.2021.04.013 · DOI
  63. Oishi, 2020, Creation of novel large dataset comprising several granulation methods and the prediction of tablet properties from critical material attributes and critical process parameters using regularized linear regression models including interaction terms, Int. J. Pharm., 577, 10.1016/j.ijpharm.2020.119083 · doi:10.1016/j.ijpharm.2020.119083
  64. Elbadawi, 2020, 3D printing tablets: Predicting printability and drug dissolution from rheological data, Int. J. Pharm., 590, 10.1016/j.ijpharm.2020.119868 · DOI
  65. Elbadawi, 2021, Harnessing Artificial Intelligence for the Next Generation of 3D Printed Medicines, Adv. Drug Deliv. Rev., 175, 10.1016/j.addr.2021.05.015 · DOI · Paper page
  66. O’Reilly, 2021, Machine Learning and Machine Vision Accelerate 3D Printed Orodispersible Film Development, Pharmaceutics, 13, 2187, 10.3390/pharmaceutics13122187 · DOI
  67. Muñiz Castro, 2021, Machine learning predicts 3D printing performance of over 900 drug delivery systems, J. Controlled Rel., 337, 530, 10.1016/j.jconrel.2021.07.046 · DOI · Paper page
  68. Miljković, 2021, Machine Learning Models for Human In Vivo Pharmacokinetic Parameters with In-House Validation, Mol. Pharm., 18, 4520, 10.1021/acs.molpharmaceut.1c00718 · DOI
  69. Wang, 2016, ADMET Evaluation in Drug Discovery Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches, Molecular Pharmaceutics, 13, 2855, 10.1021/acs.molpharmaceut.6b00471 · DOI
  70. Rohani, 2019, Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity, Sci. Rep., 9, 13645, 10.1038/s41598-019-50121-3 · DOI · Paper page
  71. Reker, 2020, Machine Learning Uncovers Food- and Excipient-Drug Interactions, Cell Reports, 30, 3710, 10.1016/j.celrep.2020.02.094 · DOI · Paper page
  72. Mai, 2019, Sex-dependence in the effect of pharmaceutical excipients: Polyoxyethylated solubilising excipients increase oral drug bioavailability in male but not female rats, Pharmaceutics, 11, 228, 10.3390/pharmaceutics11050228 · DOI
  73. Nabirotchkin, 2020, Next-generation drug repurposing using human genetics and network biology, Curr. Opin. Pharmacol., 51, 78, 10.1016/j.coph.2019.12.004 · DOI · Paper page
  74. Herrero-Zazo, 2013, The DDI corpus: An annotated corpus with pharmacological substances and drug–drug interactions, J. Biomed. Inform., 46, 914, 10.1016/j.jbi.2013.07.011 · DOI · Paper page
  75. Westphal, 2021, A machine learning method for defect detection and visualization in selective laser sintering based on convolutional neural networks, Addit. Manuf., 41
  76. Anwar, 2018, Study of the spatter distribution on the powder bed during selective laser melting, Addit. Manuf., 22, 86
  77. Zhang, 2019, Hybrid Machine Learning Method to Determine the Optimal Operating Process Window in Aerosol Jet 3D Printing, ACS Appl. Mater. Interfaces, 11, 17994, 10.1021/acsami.9b02898 · DOI
  78. Farhan, 2021, Real-time defect detection in 3D printing using machine learning, Mater. Today:. Proc., 42, 521
  79. Russell, 2019, Multifunctional motion-to-color janus transducers for the rapid detection of sepsis biomarkers in whole blood, Biosens. Bioelectron., 140, 10.1016/j.bios.2019.111346 · DOI
  80. Erenas, 2019, Real time monitoring of glucose in whole blood by smartphone, Biosens. Bioelectron., 136, 47, 10.1016/j.bios.2019.04.024 · DOI
  81. Pascucci, 2021, AI-based mobile application to fight antibiotic resistance, Nat. Commun., 12, 1173, 10.1038/s41467-021-21187-3 · DOI
  82. Haddad T.C., Helgeson J., Pomerleau K., Makey M., Lombardo P., Coverdill S., Urman A., Rammage M., Goetz M.P., LaRusso N., Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice, Journal of Clinical Oncology, 36 (2018) 6550-6550. · DOI · Paper page
  83. Karystianis G., Florez-Vargas O., Butler T., Nenadic G., A rule-based approach to identify patient eligibility criteria for clinical trials from narrative longitudinal records, JAMIA Open, 2 (2019) 521-527. · DOI
  84. Ni, 2019, A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation, JMIR Med Inform, 7, e14185, 10.2196/14185 · DOI · Paper page
  85. Perry, 2018, Use of mobile devices to measure outcomes in clinical research, 2010–2016: a systematic literature review, Digital, Biomarkers, 2, 11
  86. Pandey, 2020, Implementing healthcare services on a large scale: Challenges and remedies based on blockchain technology, Health Policy Technology, 9, 69, 10.1016/j.hlpt.2020.01.004 · DOI
  87. Mackey, 2019, A Framework Proposal for Blockchain-Based Scientific Publishing Using Shared Governance, Frontiers Blockchain, 2, 19, 10.3389/fbloc.2019.00019 · DOI
  88. Hanson-Heine, 2020, Computational chemistry experiments performed directly on a blockchain virtual computer, Chem. Sci., 11, 4644, 10.1039/D0SC01523G · DOI
  89. Kosmarski, 2020, Blockchain Adoption in Academia: Promises and Challenges, J. Open Innovation: Technology, Market Complexity, 6, 117, 10.3390/joitmc6040117 · DOI
  90. Mackey, 2015, Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment, The American journal of tropical medicine and hygiene, 92, 59, 10.4269/ajtmh.14-0389 · DOI
  91. Uddin, 2021, Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry, Int. J. Pharm., 597, 10.1016/j.ijpharm.2021.120235 · DOI · Paper page
  92. Nørfeldt, 2019, Cryptopharmaceuticals: Increasing the Safety of Medication by a Blockchain of Pharmaceutical Products, J. Pharm. Sci., 108, 2838, 10.1016/j.xphs.2019.04.025 · DOI
  93. Barba, 2020, Report on MediLedger blockchain network submitted to the FDA, Outsourcing-Pharma
  94. Lynch, 2019, Blockchain product verification solution launched, Outsourcing-Pharma
  95. Hosseini Bamakan, 2021, Blockchain-enabled pharmaceutical cold chain: Applications, key challenges, and future trends, J. Cleaner Prod., 302, 10.1016/j.jclepro.2021.127021 · DOI · Paper page
  96. Hulea, 2018, Pharmaceutical cold chain management: Platform based on a distributed ledger, 2018 IEEE International Conference on Automation, Quality and Testing, Robotics (AQTR), 1
  97. Kim, 2020, Implementation of a Blood Cold Chain System Using Blockchain Technology, Applied Sciences, 10, 3330, 10.3390/app10093330 · DOI
  98. Gupta, 2013, Fraud and misconduct in clinical research: A concern, Perspect, Clin Res, 4, 144
  99. Benchoufi, 2019, From Clinical Trials to Highly Trustable Clinical Trials: Blockchain in Clinical Trials, a Game Changer for Improving Transparency?, Frontiers in Blockchain, 2, 23, 10.3389/fbloc.2019.00023 · DOI
  100. Omar, 2020, Ensuring protocol compliance and data transparency in clinical trials using Blockchain smart contracts, BMC Med. Res. Method., 20, 224, 10.1186/s12874-020-01109-5 · DOI
  101. Benchoufi, 2017, Blockchain protocols in clinical trials: Transparency and traceability of consent, F1000Res, 6, 66, 10.12688/f1000research.10531.4 · DOI
  102. Albanese, 2020, Dynamic consent management for clinical trials via private blockchain technology, Journal of Ambient Intelligence and Humanized, Computing, 11, 4909
  103. K. F A., o S., F S., IoT technologies combining glucose control with physiological signal: comparative study, 2020 International Conference on Electrical Engineering (ICEE), 2020, pp. 1-6. · DOI
  104. Ghezzi, 2017, Oral healthcare systems for an ageing population: concepts and challenges, Int. Dent. J., 67, 26, 10.1111/idj.12343 · DOI
  105. Amalberti, 2016, Preparing national health systems to cope with the impending tsunami of ageing and its associated complexities: Towards more sustainable health care, Int. J. Qual. Health Care, 28, 412, 10.1093/intqhc/mzw021 · DOI
  106. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet, 395 (2020) 497-506. · DOI · Paper page
  107. Wakefield, 2010, A network collaboration implementing technology to improve medication dispensing and administration in critical access hospitals, J. Am. Med. Inform. Assoc., 17, 584, 10.1136/jamia.2010.004267 · DOI
  108. Casey, 2008, Implementation of telepharmacy in rural hospitals: potential for improving medication safety, Upper Midwest Rural Health Research Center
  109. Petropoulou S., Bekakos M., Gravvanis G., E-prescribing-Telepharmacy, 7th Hellenic European Conference on Computers, Citeseer, 2005, pp. 22-25.
  110. Edoh, 2017, Smart medicine transportation and medication monitoring system in EPharmacyNet, Int. Rural Elderly Health Informatics Conference (IREHI), 2017, 1
  111. Xu, 2021, Smartphone-enabled 3D printing of medicines, Int. J. Pharm., 609, 10.1016/j.ijpharm.2021.121199 · DOI
  112. Awad, 2022, Clinical translation of advanced colonic drug delivery technologies, Adv. Drug Deliv. Rev., 181, 10.1016/j.addr.2021.114076 · DOI
  113. Holdford, 2013, Adherence and persistence associated with an appointment-based medication synchronization program, J. Am. Pharm. Assoc., 53, 576, 10.1331/JAPhA.2013.13082 · DOI
  114. Berryman, 2012, Augmented reality: a review, Medical reference services quarterly, 31, 212, 10.1080/02763869.2012.670604 · DOI · Paper page
  115. Turk M., Fragoso V., Computer Vision for Mobile Augmented Reality, in: G. Hua, X.-S. Hua (Eds.) Mobile Cloud Visual Media Computing: From Interaction to Service, Springer International Publishing, Cham, 2015, pp. 3-42. · DOI
  116. Feiner, 2002, Augmented reality: A new way of seeing, Sci. Am., 286, 48, 10.1038/scientificamerican0402-48 · DOI
  117. Masood, 2019, Augmented reality in support of Industry 4.0—Implementation challenges and success factors, Rob. Comput. Integr. Manuf., 58, 181, 10.1016/j.rcim.2019.02.003 · DOI · Paper page
  118. Habig, 2020, Who can benefit from augmented reality in chemistry? Sex differences in solving stereochemistry problems using augmented reality, British J. Educational Technology, 51, 629, 10.1111/bjet.12891 · DOI · Paper page
  119. Woolman, 2020, In situ tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality, Chem. Sci., 11, 8723, 10.1039/D0SC02241A · DOI
  120. Eriksen, 2020, Visualizing 3D Molecular Structures Using an Augmented Reality App, J. Chem. Educ., 97, 1487, 10.1021/acs.jchemed.9b01033 · DOI · Paper page
  121. Forrest, 2017, Mixed Reality Meets Pharmaceutical Development, J. Pharm. Sci., 106, 3438, 10.1016/j.xphs.2017.08.020 · DOI
  122. Ingeson, 2018, Microsoft hololens-a mhealth solution for medication adherence, International Workshop on Artificial Intelligence in Health, Springer, 99
  123. Khor W.S., Baker B., Amin K., Chan A., Patel K., Wong J., Augmented and virtual reality in surgery-the digital surgical environment: applications, limitations and legal pitfalls, Ann Transl Med, 4 (2016) 454-454. · DOI · Paper page
  124. Setty, 2019, Virtual Reality Inspired Drugs (VRID): the Future Arena of Drug Discovery, SN Comprehensive Clinical Medicine, 1, 745, 10.1007/s42399-019-00117-x · DOI
  125. Alexiou A., Bouras C., Giannaka E., Kapoulas V., Nani M., Tsiatsos T., Using VR technology to support e-learning: the 3D virtual radiopharmacy laboratory, 24th International Conference on Distributed Computing Systems Workshops, 2004. Proceedings., 2004, pp. 268-273. · doi:10.1109/icdcsw.2004.1284042
  126. McDowell, 2012, Selecting a pharmacy layout design using a weighted scoring system, Am. J. Health-Syst. Pharm., 69, 796, 10.2146/ajhp100687 · DOI
  127. Johnston, 2018, Journey to the centre of the cell: Virtual reality immersion into scientific data, Traffic, 19, 105, 10.1111/tra.12538 · DOI
  128. Keller, 2017, Public Perceptions Regarding Use of Virtual Reality in Health Care: A Social Media Content Analysis Using Facebook, J. Med. Internet Res., 19, 10.2196/jmir.7467 · DOI · Paper page
  129. Fernández, 2018, Absorption of wireless radiation in the child versus adult brain and eye from cell phone conversation or virtual reality, Environ. Res., 167, 694, 10.1016/j.envres.2018.05.013 · DOI
  130. Lampton, 2000, Simulator Sickness Symptoms during Team Training in Immersive Virtual Environments, Proc. Human Factors Ergonomics Soc. Annual Meeting, 44, 530, 10.1177/154193120004400512 · doi:10.1177/154193120004400512
  131. Vincelli, 2002, Virtual reality: a new tool for panic disorder therapy, Expert Rev. Neurother., 2, 377, 10.1586/14737175.2.3.377 · DOI
  132. Raijada, 2021, Integration of personalized drug delivery systems into digital health, Adv. Drug Deliv. Rev., 176, 10.1016/j.addr.2021.113857 · DOI
  133. Kaae, 2018, Unintended consequences for patients of future personalized pharmacoprinting, International Journal of Clinical Pharmacy, 40, 321, 10.1007/s11096-018-0596-x · DOI
  134. Karavasili, 2021, Mucosal drug delivery and 3D printing technologies: A focus on special patient populations, Adv. Drug Deliv. Rev., 176, 113858, 10.1016/j.addr.2021.113858 · DOI
  135. Eleftheriadis, 2021, Automated digital design for 3D-printed individualized therapies, Int. J. Pharm., 599, 10.1016/j.ijpharm.2021.120437 · doi:10.1016/j.ijpharm.2021.120437
  136. Pawloski, 2019, A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice, J. Natl. Compr. Canc. Netw., 17, 331, 10.6004/jnccn.2018.7104 · DOI · Paper page
  137. Guo, 2020, Challenges for the evaluation of digital health solutions-A call for innovative evidence generation approaches, NPJ Digit Med, 3, 110, 10.1038/s41746-020-00314-2 · DOI · Paper page
  138. Ventola, 2019, Virtual Reality in Pharmacy: Opportunities for Clinical, Research, and Educational Applications, P T, 44, 267

Cited by

See all 178

Metadata

Authors
Trenfield, S. J., Awad, A., McCoubrey, L. E., Elbadawi, M., Goyanes, A., Gaisford, S., & Basit, A. W.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2022-03
Volume
182
Pages
114098
ISSN
0169-409X (ISSN-L)
OpenAlex
W4206620032
Cited by
178
References
38
FWCI
3.33
Type
journal article
Language
en
Open access
green
Funders
Engineering and Physical Sciences Research Council (EP/S009000/1, EP/S023054/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advancing pharmacy and healthcare with virtual digital technologies. https://app.cochat.ai/papers/10.1016/j.addr.2021.114098
The paper
Trenfield, S. J., Awad, A., McCoubrey, L. E., Elbadawi, M., Goyanes, A., Gaisford, S., & Basit, A. W. (2022). Advancing pharmacy and healthcare with virtual digital technologies. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2021.114098

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.